Chemists make historic fluorine discovery

A groundbreaking discovery by chemists at The University of Texas at San Antonio (UTSA) will have a significant impact on how pharmaceutical companies develop new drug treatments. The breakthrough involves fluorine, which ...

The impact of the rise in new drug rejections

The number of new drug applications rejected by the U.S. Food and Drug Administration has been on the rise. The cover story of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, ...

Study provides new focus for developing drugs to fight cancer

Cancer researchers and drug companies may have been too quick to ignore a promising line of inquiry that targets a specific cell protein, according to a research team led by a biomedical scientist in the School of Medicine ...

Brazil judge blocks WhatsApp for 72 hours

A Brazilian judge issued an order Monday blocking the popular WhatsApp smartphone messaging application nationwide, the second such shut-down in six months.

Lawsuit accuses CVS of overcharging for generic drugs

CVS Health Corp. deliberately overcharged some pharmacy customers for generic drugs by submitting claims to their insurance companies at inflated prices, according to a lawsuit filed Thursday in federal court in San Francisco.

Team helps cancer treatment drugs get past their sticking point

Potentially valuable drugs slowed down by sticky molecules may get another shot at success. Joint research by the National Institute of Standards and Technology (NIST), Genentech, the University of Delaware and Institut Laue-Langevin ...

page 6 from 8